EFEM
BSX icon

Eos Focused Equity Management’s Boston Scientific BSX Stock Holding History

Eos Focused Equity Management’s Portfolio BSX Stock Details BSX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q4 		– Sell
-7,777
Closed -$337K – 26
2021
Q3 		$337K Buy
+7,777
New +$344K 0.26% 29

Other funds holding BSX

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London $209B AUM 37.72% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return
BG
Bollard Group Boston, Massachusetts $3.29B AUM 4.86% 1-Year Est. Return

Eos Focused Equity Management's BSX Position: Q4 2021 in Review

Eos Focused Equity Management sold out of Boston Scientific (BSX) in Q4 2021, closing a stake of 7,777 shares — an estimated $337K sold.

Eos Focused Equity Management first reported a position in BSX in Q3 2021 and held it in 1 quarter. The position peaked at $337K in Q3 2021. 889 funds tracked by Wall St. Rank hold BSX as of Q4 2021.

  • Eos Focused Equity Management reported no remaining Boston Scientific position as of Q4 2021 after selling out during the quarter.
  • Eos Focused Equity Management sold 7,777 Boston Scientific shares in Q4 2021, an estimated $337K.
  • Eos Focused Equity Management first reported a position in Boston Scientific in Q3 2021 and held it in 1 quarter.
  • Eos Focused Equity Management's Boston Scientific position peaked at $337K in Q3 2021.
  • 889 funds tracked by Wall St. Rank held Boston Scientific as of Q4 2021.

Based on Eos Focused Equity Management's 13F filing for Q4 2021, filed 2 Feb 2022.